The year 2022 was a year full of scientific and regulatory achievements for the Biotherapy Partners team, which had the opportunity to collaborate on 16 different projects.
Among them, 6 gene therapy projects, 2 cell therapy projects, 2 live biotherapeutics, 1 biologicals and 5 training program, resulting in 5 EU Scientific Advices, 1 FDA type B meeting & 1 IND. We look forward to 2023!
